公司资料
Precigen 股价、新闻与催化剂
- 股票代码:
- PGEN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
7.17 USD (-0.42%)
收盘价
最后更新: 2026年8月24日
1.38B USD
市值
股价为何变动
As of Aug 24, 2026, PGEN closed down 0.42% at $7.17. No new same-company headline was identified in the current news window.
公司概览
业务概览
Precigen is a biotechnology company focused on gene and cell therapies, as well as engineered biologics. Its platform aims to create novel treatments across several disease areas.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Precigen sits in advanced biotechnology.
商业模式特征
The company depends on platform validation, clinical data, and the ability to convert engineered biology into value.
生物医药行业定位
Precigen is a platform biotech name whose stock reacts to progress in cell and gene therapy programs.
未来催化剂
- Precigen’s catalysts are PRGN-2012 and its UltraCAR-T platform, especially any update in recurrent respiratory papillomatosis or other immuno-oncology programs. The company needs to keep proving the platform can produce tangible clinical value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。